IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1144
Positioning
Market Dominance
Finance, Insurance, And Real Estate
Insurance
$3.5B
John E. Kao
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$SII SPROTT INC. | 75 | 91 | 87 | 98 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PUK PRUDENTIAL PLC | 73 | 88 | 97 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NMR NOMURA HOLDINGS INC | 72 | 81 | 92 | 87 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PSLV Sprott Physical Silver Trust | 69 | 82 | 80 | 98 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UFCS UNITED FIRE GROUP INC | 68 | 81 | 93 | 76 | 5.0x | 3.5x | 13.2% | 4.1% | 99.9% | 14.7% | 11.1% | 9.2% | 2.1% | 16.0x | $775M | VS | |
$SLF SUN LIFE FINANCIAL INC | 68 | 83 | 95 | 63 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$CBOE Cboe Global Markets, Inc. | 68 | 75 | 63 | 77 | 21.3x | 15.7x | 24.0% | 13.7% | 41.7% | 32.4% | 26.4% | 8.2% | 1.1% | 30.0x | $25.7B | VS | |
$VTMX Vesta Real Estate Corporation, S.A.B. de C.V. | 67 | 69 | 77 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PHYS Sprott Physical Gold Trust | 67 | 64 | 82 | 91 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GLDM World Gold Trust | 66 | 54 | 85 | 92 | 11.3x | 11.3x | - | 20.9% | 100.0% | 97.1% | 554.8% | -19.0% | 0.0% | - | $32.0B | VS | |
$ALHC Alignment Healthcare, Inc. | 56 | 67 | 46 | 88 | 995.0x | 120.1x | -10.1% | -1.5% | 100.0% | -0.1% | -0.7% | 45.9% | 0.0% | 199.0x | $3.5B | ||
| SECTOR BENCH | - | - | - | - | - | 11.9x | 7.8x | 9.0% | 1.3% | 77.7% | 18.1% | 21.9% | 10.7% | 2.0% | 0.5x | - | REF |
Alignment Healthcare, Inc. (ALHC) receives a "Hold" rating with a composite score of 56.0/100. It ranks #1144 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
High profitability & efficiency — strong quality floor supports entry
Average volatility — neutral timing signal
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Finance, Insurance, And Real Estate sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for ALHC.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 67 | 89 | -22DRAG |
| MOMENTUM | 88 | 95 | -7DRAG |
| VALUATION | 46 | 57 | -11DRAG |
| INVESTMENT | 24 | 12 | +12ALPHA |
| STABILITY | 37 | 30 | +7ALPHA |
| SHORT INT | 42 | 40 | +2NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -10.1% (sector 9.0%)
GM 100% vs sector 78%, OM -0% vs sector 18%
Capital turnover N/A
Rev growth 46%, 5yr history
Interest coverage 1.9x, Net debt/EBITDA -18.9x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Alignment Healthcare, Inc. (ALHC) as a Hold with a composite score of 56.0/100 at a current price of $19.59. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
Alignment Healthcare, Inc. holds a top-quartile position (#0 of 50) within the Finance, Insurance, And Real Estate sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 56.0/100 places it at rank #1144 in our full universe.
The near-term outlook is constructive, with revenue growing at 46% and momentum in the 88th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
Narrow
High
Poor
Fair Value
Gross margins of 100% signal strong pricing power.
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Elevated P/E ratio of 995.0x leaves little room for execution misses.
Leverage of 199% D/E amplifies downside risk.
Vulnerability to macroeconomic shocks and interest rate volatility.
Alignment Healthcare, Inc. represents a hold based on multi-factor quantitative performance.
Our model assigns Alignment Healthcare, Inc. a Hold rating, with a composite score of 56.0/100 and 3 out of 5 stars. Ranked #1144 of 7,333 stocks, ALHC presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
ALHC earns a quality score of 67/100, indicating above-average business quality. The company reports a return on equity of -10.1% (sector avg: 9.0%), gross margins of 100.0% (sector avg: 77.7%), net margins of -0.7% (sector avg: 21.9%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
With a value score of 46/100, ALHC appears somewhat expensive relative to its fundamentals. Key valuation metrics include a P/E ratio of 995.00x, an EV/EBITDA of 120.08x, a P/B ratio of 24.60x. Investors paying a premium here are likely betting on above-average growth or margin expansion to justify current prices.
Alignment Healthcare, Inc.'s investment score of 24/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 45.9% vs. a sector average of 10.7% and a return on assets of -1.5% (sector: 1.3%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
ALHC shows strong momentum characteristics with a score of 88/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 45.9% year-over-year, while a beta of 0.06 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
ALHC's stability score of 37/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.06 and a debt-to-equity ratio of 199.00x (sector avg: 0.5x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
The short interest score of 42/100 for ALHC suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 199.00x). With a $3.5B market cap (mid-cap), Alignment Healthcare, Inc. may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
Alignment Healthcare, Inc. is a mid-cap company in the Finance, Insurance, And Real Estate sector, ranked #0 of 50 in its sector (100th percentile) and #1144 of 7,333 overall (84th percentile). Key comparisons include ROE of -10.1% trailing the 9.0% sector median and operating margins of -0.1% below the 18.1% sector average. This top-quartile standing reflects exceptional competitive strength relative to Finance, Insurance, And Real Estate peers.
While ALHC currently exhibits a HOLD profile, superior opportunities exist within the FINANCE, INSURANCE, AND REAL ESTATE sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Finance, Insurance, And Real Estate Alpha →Quant Factor Profile
Key factor gap
Momentum (88) vs Investment (24) — closing this gap could shift the rating.
EV/EBITDA 1445% ABOVE SECTOR MEDIAN
ROE 213% BELOW SECTOR MEDIAN
Gross Margin 29% ABOVE SECTOR MEDIAN (FAVORABLE)
Above 50MA
37.18%
Net New Highs
+51081
General Atlantic, a 10% owner of Alignment Healthcare, sold 11.1 million shares for $206.5 million on December 12, 2025, representing a 45.2% reduction in its stake. The sale occurred at $18.57 per share, slightly below the market close of $19.36, following a 74% stock price increase over the prior year. While Alignment Healthcare reported strong Q3 2025 results with 43.5% revenue growth and 31% membership growth, the insider selling and projected Medicare Advantage enrollment decline in 2026 warrant investor caution.
Health insurance company Alignment Healthcare (NASDAQ:ALHC) will be reporting results this Thursday after market hours. Here’s what investors should know.
ORANGE, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), today announced that it will present at the Leerink Partners Global Healthcare Conference in Miami, Florida, on Tuesday, March 10, at 3:40 p.m. EST. A webcast and replay of the presentation will be available on Alignment’s investor relations website at https://ir.alignmenthealth.com/. About Alignment HealthcareAlignment Health is championing a new path in senior care that empowers members to age well and
Alignment Healthcare, Inc. (NASDAQ:ALHC) is among the 15 Innovative Healthcare Stocks to Buy According to Analysts. The next stock on our list is Alignment Healthcare, Inc. (NASDAQ:ALHC). TheFly reported on January 30 that Baird increased its price target on ALHC to $28 from $22 while maintaining an Outperform rating. After updating its financial model, the firm now believes there is significant […]
On February 10, 2026, Alignment Healthcare disclosed that CEO John E. Kao and CHRO Andreas Wagner sold shares under a pre-arranged plan and to cover taxes, while the company projected health plan membership growth of 24–27% for 2026 following a 31% year-over-year increase as of January 1. This combination of strong membership momentum and analyst upgrades, set against routine insider sales, highlights how operating performance is currently shaping investor expectations for Alignment’s...